Financials
- Market Capitalization 2.73 B
- Employee 10
- Founded 2014
- CEO N/A
- Website www.regencellbioscience.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-23.67
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1260 | AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 18.01 USD | +0.11% | +0.11% | -4.71% | +70.71% | 5.75 B USD | ||
| 1497 | INDV Indivior Pharmaceuticals, Inc. - Common Stock | 35.30 USD | -1.48% | -6.32% | -14.49% | +5.06% | 4.17 B USD | ||
| 1842 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 44.19 USD | -1.54% | -5.84% | -6.81% | -18.17% | 2.57 B USD | ||
| 1883 | PBH Prestige Consumer Healthcare Inc. Common Stock | 51.19 USD | -1.97% | +2.09% | -0.58% | -24.14% | 2.43 B USD |